No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Alectinib Improves Disease-Free Survival in ALK-Positive Non-Small-Cell Lung Cancer Compared to Platinum-Based Chemotherapy

byBryan SunandMinjee Kim

April 18, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in The New England Journal of Medicine.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

Ivonescimab improves survival in advanced non-small cell lung cancer

AstraZeneca’s Imfinzi shows positive results in phase 3 trial for treatment of limited-stage small cell lung cancer

Humanetics Corporation: BIO 300 Synthetic Genistein Nanosuspension May Protect Against Negative Effects Of Radiation Therapy In Lung Cancer Patients

RelatedReports

Lessons from real-world implementation of lung cancer screening

AI Roundup

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

June 10, 2025

Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025

Dacomitinib may be effective in EGFR-associated lung cancer

Pharma

AstraZeneca’s Imfinzi shows positive results in phase 3 trial for treatment of limited-stage small cell lung cancer

December 30, 2024

Oncology

RAMOSE Phase II trial finds promising results for osimertinib and ramucirumab in non-small cell lung cancer

December 10, 2024

#VisualAbstract: Addition of metronidazole is nonsuperior to conventional antibiotic prophylaxis in preventing pelvic cellulitis and pelvic abscess after total laparoscopic hysterectomy

The 2 Minute Medicine Podcast Episode 15

The 2 Minute Medicine Podcast Episode 38

Adjunctive TMP-SMX (Bactrim) associated with higher clinical cure rates for cutaneous abscesses

2 Minute Medicine Rewind April 22, 2024

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result